- Home
- RITM vs PTCT Comparison
RITM vs PTCT Comparison
Compare RITM & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RITM | PTCT |
|---|---|---|
| Founded | 2011 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 5.3B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | RITM | PTCT |
|---|---|---|
| Price | $11.13 | $75.70 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 17 |
| Target Price | $14.25 | ★ $73.76 |
| AVG Volume (30 Days) | ★ 5.2M | 2.2M |
| Earning Date | 10-30-2025 | 11-04-2025 |
| Dividend Yield | ★ 9.00% | N/A |
| EPS Growth | ★ 46.96 | N/A |
| EPS | 1.45 | ★ 8.94 |
| Revenue | ★ $3,961,432,000.00 | $1,779,150,000.00 |
| Revenue This Year | N/A | $128.32 |
| Revenue Next Year | $8.20 | N/A |
| P/E Ratio | ★ $7.66 | $8.46 |
| Revenue Growth | 32.03 | ★ 97.54 |
| 52 Week Low | $9.13 | $35.95 |
| 52 Week High | $12.74 | $87.50 |
Technical Indicators
Market Signals| Indicator | RITM | PTCT |
|---|---|---|
| Relative Strength Index (RSI) | 48.15 | 50.79 |
| Support Level | $10.98 | $73.09 |
| Resistance Level | $11.32 | $78.77 |
| Average True Range (ATR) | 0.19 | 3.15 |
| MACD | -0.02 | -1.02 |
| Stochastic Oscillator | 23.20 | 18.45 |
Price Performance
Historical ComparisonAbout RITM Rithm Capital Corp.
Rithm Capital Corp operates as a real estate investment trust that provides capital and services to the real estate and financial services industries. The company aims to generate attractive risk-adjusted returns in all interest-rate environments through a complementary portfolio of investments and operating businesses. Its investment portfolio is composed of mortgage servicing-related assets (full and excess MSRs and servicer advances), residential securities (and associated call rights) loans (including single-family rental), and consumer loans. Its operating segments are Origination and Servicing; Investment Portfolio; Residential Transitional Lending; and Asset Management.
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.